Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
AZTA
Azenta, Inc.
Azenta, Inc. (AZTA) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (A); its weakest is Value (C-).
Quantitative Factor Evaluation • Updated
Overall Rating
2.8
/ 5.0
C+
Value
C-
Factor Score
2.0
/ 5.0
Growth
C
Factor Score
2.4
/ 5.0
Profitability
C+
Factor Score
2.8
/ 5.0
Momentum
A
Factor Score
4.3
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
53.1
EV / EBITDA
46.9
Rev Growth YoY
5.1%
Gross Margin
44.2%
Price Return 3M
43.2%
Price Return 12M
58.0%
Catalyst Signal
0.00
Market Cap
$2.0B
TTM Revenue
$621.7M
Price / Sales
3.2
ROE
-10.1%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | C- (2.0) | C (2.4) | C+ (2.8) | A (4.3) | C+ (2.6) | C+ (2.8) |
| 2026-11-10 | D+ (1.6) | C+ (2.8) | C+ (2.8) | A (4.2) | C+ (2.6) | C+ (2.8) |
| 2026-11-03 | C- (2.0) | C+ (2.8) | C+ (2.8) | A- (4.1) | C+ (2.7) | B- (2.9) |
| 2026-10-27 | C- (1.9) | C+ (2.8) | C+ (2.8) | B+ (3.6) | C+ (2.6) | C+ (2.8) |
| 2026-10-20 | C- (2.1) | C+ (2.8) | C+ (2.8) | B+ (3.5) | C+ (2.6) | C+ (2.8) |
Page
1
of
4